Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

1590 projects found matching your search criteria :

  1. The [60]fullerene-based theranostic agent for pancreatic cancers treatment and diagnosis

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr Maciej Michał Serda

    Uniwersytet Śląski w Katowicach, Wydział Nauk Ścisłych i Technicznych

  2. Lactoferrin and versatile polymers as a tool for selective and targeted delivery of anticancer hydrophobic drugs in the ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Przemysław Krzysztof Gajda-Morszewski

    Uniwersytet Jagielloński, Wydział Chemii

  3. Curcuminoid-polyphenol conjugates as potential therapeutics for urinary system cancer treatment

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Gośliński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  4. Exploring the role and therapeutic potential of sex hormone binding globulin (SHBG) in the course of insulin resistance,...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Krzysztof Mariusz Marycz

    Uniwersytet Przyrodniczy we Wrocławiu, Wydział Biologii i Hodowli Zwierząt

  5. Design and synthesis of proteolytically stable and cell permeable activators of human 20S proteasome and assessing their...

    Call: PRELUDIUM BIS 1 , Panel: NZ7

    Principal investigator: dr hab. Elżbieta - Jankowska

    Uniwersytet Gdański, Wydział Chemii

  6. Kappa opioid receptors integrate neuronal signaling involved in social behavior

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: dr hab. Jan Manuel Rodriguez Parkitna

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. Assessment of the hepatoprotective effect of AP39, a new H2S donor, in a model of autoimmune hepatitis in mice.

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: dr Katarzyna Paulina Przejczowska-Pomierny

    Uniwersytet Jagielloński, Collegium Medicum

  8. Molecular mechanisms of interplay between RORγ/RORγT receptors and cyclin-dependent kinase inhibitor (AT7519). Analysis ...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Kaja Urszula Karaś

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  9. Biotic and abiotic stress elicitors as modulators of isoquinoline alkaloid profile towards specific antimicrobial proper...

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr hab. Sylwia Zielińska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

  10. Gamma-glutamylcysteine ligase participation in the antioxidant mechanism of action of sulodexide on vascular endothelial...

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Klaudia Katarzyna Bontor

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  11. Nanoplastic toxicity: effect on gut-brain axis

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Marcin Konrad Kruszewski

    Instytut Chemii i Techniki Jądrowej

  12. Which patients with rheumatoid arthritis or axial spondyloarthritis without classical cardiovascular risk factors have m...

    Call: PRELUDIUM 18 , Panel: NZ5

    Principal investigator: Jarosław Łukasz Nowakowski

    Uniwersytet Jagielloński, Collegium Medicum

  13. Seeking for CB1 and CB2 receptor ligands among drugs, drug metabolites, and phytochemical compounds

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Adam Stasiulewicz

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  14. Fluorine substitution – a new algorithm for increasing biological activity

    Call: PRELUDIUM 18 , Panel: NZ7

    Principal investigator: Wojciech Pietruś

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  15. Investigation of novel functionally selective opioid receptors agonists

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Łucja Elżbieta Szumiec

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Identification of molecular mechanism of Escherichia coli response to antimicrobial blue light inactivation by genome-wi...

    Call: SONATINA 4 , Panel: NZ7

    Principal investigator: dr Aleksandra Małgorzata Rapacka-Zdończyk

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

  17. Influence of modified maternal diet on the phenotype of offspring: behavioral and molecular correlations

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Kinga Gawlińska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. Towards innovative strategy for treatment of Alzheimer's Disease via dual inhibition of receptor 5-HT6 and kinase CDK5.

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Sylwia Sudoł-Tałaj

    Uniwersytet Jagielloński, Collegium Medicum

  19. Evaluation of the potential use of noble metal nanoparticles as drug delivery platforms in an experimental model of infl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Karol Paweł Steckiewicz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  20. New multifunctional drug-like ligands focusing on molecular targets associated with the symptoms and causes of Alzheimer...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Anna Marta Pasieka

    Uniwersytet Jagielloński, Collegium Medicum

  21. Assessment of the ability of application of folic acid and/or transferrin as alinkers between conjugates of quantum dots...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Joanna Pilch

    Politechnika Gdańska

  22. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  23. Modern nanoparticle and model organism - a toxic relation? Physiological and cellular causes of developmental disorders ...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: prof. Maria Jadwiga Augustyniak

    Uniwersytet Śląski w Katowicach, Wydział Nauk Przyrodniczych

  24. Photodynamic therapy combined with PD-1/PD-L1 blockade immunotherapy: new possibilities for the treatment of immunogenic...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr hab. Janusz Marcin Dąbrowski

    Uniwersytet Jagielloński, Wydział Chemii

  25. The effect of methylated resveratrol analogue 3,4,4',5-tetramethoxystilbene (DMU-212) on secretion profile and different...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Małgorzata Józkowiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  26. The impact of state-ownership in the banking sector on the systemic risk and the feasibility of resolution mechanism

    Call: PRELUDIUM 19 , Panel: HS4

    Principal investigator: Kamil Klupa

    Szkoła Główna Handlowa w Warszawie, Kolegium Zarządzania i Finansów

  27. Interactions of plant extracts traditionally used in skin diseases with a human skin microbiota

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: prof. Sebastian Granica

    Warszawski Uniwersytet Medyczny

  28. Impairment of coronary microcirculation in a mouse model of a heart failure

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Grzegorz Stanisław Kwiatkowski

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

  29. Epidemiology and rapid spread of antimicrobial resistance amongAcinetobacter spp. strains in hospital units - analysis u...

    Call: PRELUDIUM BIS 2 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Chmielarczyk

    Uniwersytet Jagielloński, Collegium Medicum

  30. Influence of the route of administration of new psychoactive substances on their metabolic profile

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr Magdalena Anna Popławska

    Narodowy Instytut Leków

  31. Novel insights into the mechanisms and consequences of early vascular aging: focus on the role of emerging modifiable ca...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: prof. Krzysztof Olgierd Narkiewicz

    Gdański Uniwersytet Medyczny, Wydział Lekarski

  32. Molecular mechanism of the protective effect of swimming training on skeletal muscle atrophy and the course of amyotroph...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: prof. Wiesław Ziółkowski

    Gdański Uniwersytet Medyczny, Wydział Nauk o Zdrowiu z Instytutem Medycyny Morskiej i Tropikalnej

  33. Nanoplastic and silver nanoparticles as a factor modulating the activity of estrogen-dependent intracellular signaling p...

    Call: OPUS 20 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Maria Grzelak

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  34. New approach to membrane scaling risk assessment - combining nucleation kinetics with residence time distribution

    Call: OPUS 7 , Panel: ST8

    Principal investigator: prof. Marian Turek

    Politechnika Śląska, Wydział Chemiczny

  35. Molecular mechanism of action of antidepressant drugs in the in vitro model of contact allergy in the human cell line Ha...

    Call: PRELUDIUM 7 , Panel: NZ6

    Principal investigator: Katarzyna Curzytek

    Instytut Farmakologii PAN

  36. The role of the factors involved in the brain glucose metabolism in the model of obesity and depression comorbidity

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: prof. Bogusława Budziszewska

    Instytut Farmakologii PAN

  37. Impact of nanoparticles on cellular signaling activated by tumor necrosis factor

    Call: SONATA 7 , Panel: NZ7

    Principal investigator: dr Kamil Brzóska

    Instytut Chemii i Techniki Jądrowej

  38. Elder neglect and self-neglect - challenges for formal and informal caregivers and medical and social professional care ...

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: prof. Tomasz Grodzicki

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Lekarski

  39. Insurer's solvency, portfolio immunization and incomplete markets

    Call: OPUS 7 , Panel: HS4

    Principal investigator: prof. Lesław Gajek

    Politechnika Łódzka, Wydział Fizyki Technicznej, Informatyki i Matematyki Stosowanej

  40. Risk factors for congenital and postnatal cytomegalovirus infection

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: dr hab. Edyta Paradowska

    Instytut Biologii Medycznej PAN

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy